Back to results
US 9,540,414 B2Granted
TGR5 modulators and methods of use thereof
AssigneeIntercept Pharmaceuticals, Inc.
InventorRoberto Pellicciari
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds of Formula A: or a salt, solvate, or hydrate thereof. The compounds of formula A are TGR5 modulators useful for the treatment of disease.
Claims2
A compound of formula A:
- or a salt thereof, wherein:
- R1 is hydrogen, hydroxy, substituted or unsubstituted alkyl, or halogen;
- R2 is hydrogen or a-hydroxy;
- R4 is substituted or unsubstituted alkyl, or halogen;
- R5 is hydrogen, unsubstituted alkyl, or aryl;
- R6 is hydrogen, unsubstituted or substituted alkyl, or R5 and R6 taken together with the carbons to which they are attached form a ring of size 3, 4, 5, or 6 atoms;
- R7 is hydrogen, substituted or unsubstituted alkyl, or hydroxy;
- R11 is hydroxyl, OSO3H, OSO3−, OCOCH3, OPO3H, OPO32− or hydrogen;
- R12 is hydroxyl, OSO3H, OSO3−, OCOCH3, OPO3H, OPO32− or hydrogen, or taken together R11 and R12 form a carbonyl;
- m is 0, 1, or 2;
- n is 0 or 1;
- o is 0 or 1;
- and
- p is 1;
- provided that
- m+n+o=3 or 4 and
- when m+n+o=3, then at least one of R5 and R6 is not hydrogen.
14 more elements
Dependencies are inferred from the claim text.